EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

 30.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 51.00p
  • 52 Week Low: 25.60p
  • Currency: UK Pounds
  • Shares Issued: 454.93m
  • Volume: 0
  • Market Cap: £136.48m

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: David Michael Salter
CFO: Marc Davies
Non-Executive Chairman: Christopher H B Mills
Non-Executive Deputy Chairman: Julian Baines
Non-Executive Dir: Christian Alexander Rigg , Jenny Winter

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 30.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 51.00p
52 Week Low 25.60p
Volume 0
Shares Issued 454.93m
Market Cap £136.48m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.34% below the market average73.34% below the market average73.34% below the market average73.34% below the market average73.34% below the market average
72.13% below the sector average72.13% below the sector average72.13% below the sector average72.13% below the sector average72.13% below the sector average
Price Trend
69.44% below the market average69.44% below the market average69.44% below the market average69.44% below the market average69.44% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average
Income
14.71% below the market average14.71% below the market average14.71% below the market average14.71% below the market average14.71% below the market average
62.67% below the sector average62.67% below the sector average62.67% below the sector average62.67% below the sector average62.67% below the sector average
Growth
0.53% above the market average0.53% above the market average0.53% above the market average0.53% above the market average0.53% above the market average
4.27% below the sector average4.27% below the sector average4.27% below the sector average4.27% below the sector average4.27% below the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for --2023

Time Volume / Share Price
0 @ 0.000p

EKF Key Personnel

CEO David Michael Salter
CFO Marc Davies

Top of Page